Pharmaceuticals startups that filed an SEC Form D
WhoFiled tracks 64 Pharmaceuticals companies that disclosed a raise through an SEC Form D filing, most recently on November 10, 2026. Each entry links to the full Form D filing detail, reported amount and round stage.
Recent Pharmaceuticals Form D filings
- Orcosa Inc. — SEC Form D filed November 10, 2026, $6.00M reported, Series A.
- GOA Therapeutics Corp — SEC Form D filed November 5, 2026, $300K reported, Pre-seed, based on an initial $300,000 equity financing round to fund early preclinical development..
- BridgeHealth Pharmaceuticals, Inc. — SEC Form D filed November 5, 2026, $3.50M reported, Seed.
- Vesalius Longevity Labs Inc. — SEC Form D filed November 3, 2026, $30.11M reported, Growth stage, driven by a $30.1 million equity raise and a planned public listing via a reverse-takeover transaction..
- Coeurative, Inc. — SEC Form D filed October 13, 2026, $100K reported, Pre-Seed.
- EpiVario Inc. — SEC Form D filed October 13, 2026, $185K reported, Pre-seed stage based on the small $185,000 debt raise intended for early research and operational runway..
- DSIpharma, Inc. — SEC Form D filed October 2, 2026, $951K reported, Seed.
- Amani Therapeutics, Inc. — SEC Form D filed October 1, 2026, $35.00M reported, Series A.
- Dignify Therapeutics, LLC — SEC Form D filed September 25, 2026, $800K reported, Seed, because an $800,000 debt round is typical for an early-stage pharmaceutical company funding preclinical validation and initial regulatory filings..
- Aponia Laboratories Inc — SEC Form D filed September 24, 2026, Pre-Seed.
- Functional Longevity Labs, Inc. — SEC Form D filed September 21, 2026, $25K reported, Pre-Seed.
- Quoin Pharmaceuticals Ltd. — SEC Form D filed September 10, 2026, $50.00M reported.
- Immunophotonics, Inc. — SEC Form D filed September 4, 2026, $10.15M reported, Series B because a ten million dollar equity raise typically supports mid-stage clinical trials and pipeline expansion for biotechnology corporations..
- DalCor Pharmaceuticals US, LLC — SEC Form D filed August 28, 2026, $6.96M reported, Series A because a $6.9 million equity raise is typical for an early-stage clinical biotechnology company transitioning into larger clinical trials..
- Sentonix, Inc. — SEC Form D filed August 20, 2026, $12.70M reported.
- ELLA LEROY Corp — SEC Form D filed August 11, 2026, $50K reported, Pre-Seed.
- PLEOPHARMA, INC. — SEC Form D filed August 10, 2026, $5.50M reported, Series A.
- InnovoTEX Inc. — SEC Form D filed August 6, 2026, $750K reported, Seed.
- Ratio Therapeutics, Inc. — SEC Form D filed July 31, 2026, $70.00M reported, Series B+.
- Pharmazz, Inc. — SEC Form D filed July 28, 2026, $250K reported, Seed.
- Carnot Labs, Inc. — SEC Form D filed July 23, 2026, $4.95M reported.
- Rhoshan Pharmaceuticals, Inc. — SEC Form D filed July 22, 2026, $3.10M reported.
- Jaguar Health, Inc. — SEC Form D filed June 30, 2026, $40.80M reported, Series B+.
- FibroBiologics, Inc. (FBLG) — SEC Form D filed June 29, 2026, $3.00M reported.
- Crossject SA — SEC Form D filed June 5, 2026, $10.26M reported, Seed.
- Spine BioPharma, Inc. — SEC Form D filed June 5, 2026, $385K reported, Seed.
- Lantern Pharma Inc. — SEC Form D filed May 21, 2026.
- Sea Pharmaceuticals, LLC — SEC Form D filed May 20, 2026, $71K reported.
- CNS Pharmaceuticals, Inc. — SEC Form D filed May 19, 2026, $22.52M reported, Seed.
- Pagari Life Science Corp. — SEC Form D filed May 12, 2026, $97K reported, Seed.
- Niche Biopharmaceuticals LLC — SEC Form D filed May 11, 2026, $200K reported, Seed.
- Natsar Pharmaceuticals, Inc. — SEC Form D filed May 8, 2026, $4.22M reported, Seed.
- MycoRx LLC — SEC Form D filed May 8, 2026, $600K reported, Seed.
- Lighthouse Pharmaceuticals, Inc. — SEC Form D filed May 7, 2026, $15.21M reported, Series A.
- Esanik Therapeutics, Inc. — SEC Form D filed April 30, 2026, $200K reported, Seed.
- Nutrivert Inc. — SEC Form D filed April 29, 2026, $2.37M reported, Seed.
- Certara, Inc. (CERT) — SEC Form D filed April 28, 2026, $8.62M reported, Series A.
- General Oncology, Inc. — SEC Form D filed April 23, 2026, $4.81M reported, Pre-Seed.
- Ionetix Corp / DE / — SEC Form D filed April 23, 2026, $32.33M reported, Seed.
- KIORA PHARMACEUTICALS INC (KPRX, KPHMW) — SEC Form D filed April 21, 2026, $5.00M reported, Seed.
- KIORA PHARMACEUTICALS INC — SEC Form D filed April 21, 2026, $5.00M reported, Seed.
- TelyRx Finco Inc. — SEC Form D filed April 20, 2026, $12.62M reported, Seed.
- HUBOT, INC. — SEC Form D filed April 7, 2026, $5.50M reported, Seed.
- Spectrum Antimicrobials, Inc. — SEC Form D filed April 1, 2026, $26.39M reported, Seed.
- Apnimed, Inc. — SEC Form D filed March 27, 2026, $25.00M reported.
- AN2 Therapeutics, Inc. — SEC Form D filed March 25, 2026, $40.00M reported.
- Dosentrx Ltd. — SEC Form D filed March 19, 2026, $1.78M reported.
- PIROUETTE PHARMA INC. — SEC Form D filed March 18, 2026, $1.08M reported, Seed.
- Nocion Therapeutics, Inc. — SEC Form D filed March 13, 2026, $23.00M reported, Series B+.
- DNA SEQ 2, INC. — SEC Form D filed March 11, 2026, $1.18M reported, Seed.
- ADVAC Therapeutics Inc — SEC Form D filed March 10, 2026, $500K reported.
- MindImmune Therapeutics, Inc. — SEC Form D filed March 5, 2026, $15.22M reported, Seed.
- NANOVIRICIDES, INC. — SEC Form D filed February 25, 2026, $6.00M reported, Series A.
- Altesa BioSciences, Inc. — SEC Form D filed February 23, 2026, $75.00M reported, Seed.
- Galenus Precision Pharmacy, Inc. — SEC Form D filed February 18, 2026, $1.94M reported, Seed.
- Akava Therapeutics Inc. — SEC Form D filed February 18, 2026, $15.00M reported, Seed.
- Accretion Therapeutics, Inc. — SEC Form D filed February 17, 2026, $750K reported, Series A.
- LEXICON PHARMACEUTICALS, INC. — SEC Form D filed February 17, 2026, $55.67M reported, Series A.
- NovaBay Pharmaceuticals, Inc. — SEC Form D filed January 27, 2026, $134.00M reported, EMERYVILLE, California, United States.
- NBO Pharma Inc. — SEC Form D filed January 22, 2026, $7.64M reported, Pre-Seed.
- CYBIN INC. — SEC Form D filed January 12, 2026, $114K reported, Series B+, Toronto, Canada.
- LivFul Inc. — SEC Form D filed December 16, 2025, $250K reported, Pre-seed.
- Revalesio Corp — SEC Form D filed December 16, 2025, $38.88M reported, Series B+.
- FibroBiologics, Inc. — SEC Form D filed December 16, 2025, $1.73M reported, Seed.
Other sectors
- Biotechnology Form D filings (502)
- Other Technology Form D filings (254)
- Medical Devices Form D filings (165)
- Other Form D filings (158)
- Healthcare Technology Form D filings (144)
- Technology Form D filings (108)
- Food & Beverage Form D filings (107)
- Fintech Form D filings (103)
- Artificial Intelligence Form D filings (91)
- Cybersecurity Form D filings (73)
- Manufacturing Form D filings (72)
- Financial Technology Form D filings (69)
- Health Care Form D filings (65)
- Health Technology Form D filings (57)
- Other Health Care Form D filings (51)
- Mining Form D filings (49)
- Retail Form D filings (47)
- Financial Services Form D filings (43)
- Construction Technology Form D filings (42)
- Energy Form D filings (39)
- Education Technology Form D filings (37)
- Health & Wellness Form D filings (35)
- EdTech Form D filings (34)
- Sports Technology Form D filings (34)